ROCKWELL MEDICAL, INC. — Form 10-Q
Filed August 13, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
Mark Strobeck (CEO) and Jesse Neri (CFO) provided standard Sarbanes-Oxley certifications for Rockwell Medical's Q2 2026 10-Q filing dated August 13, 2026. The certifications confirm no untrue material statements, fair presentation of financials, and proper design of disclosure controls and internal controls over financial reporting. No material weaknesses, deficiencies, or fraud are disclosed.
Why this rating
Routine SOX certifications; boilerplate exhibit with no substantive business changes, transactions, or control issues reported.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.